Argis Pharmaceuticals

Argis Pharmaceuticals is a Turkish pharmaceutical company focused on managing the stages of pre-formulation, formulation, process, and stability in the development of drugs. Established in 2006, the company offers outsourcing manufacturing and analysis services to its business partners. Argis Pharmaceuticals operates in a 3000 m² GMP-certified production facility approved by the Turkish Ministry of Health, equipped with modern machinery, laboratories, and offices to meet the high product requirements of the pharmaceutical industry. Their outsourcing manufacturing services encompass a wide range of solid, semi-solid, and liquid production, including shaping and filling machines. The company's pharmaceutical production forms include tablets, capsules, dragees, sachets, granules, ovules, suppositories, dry powders for suspension, drops, syrups, solutions, oral gargles, creams, pomades, gels, emulsions, lotions, non-aerosol sprays, and suspensions. Argis Pharmaceuticals operates within the digital health, health care, health and wellness, and healthtech industries. Currently, there is no publicly available information regarding the company's last investment or the involved investors. For further inquiries, individuals can reach out to [email protected] or [email protected].